Amphastar Pharmaceuticals, Inc. (AMPH)
25.43
+0.08
(+0.32%)
USD |
NASDAQ |
Oct 02, 16:00
25.44
+0.01
(+0.04%)
After-Hours: 20:00
Amphastar Pharmaceuticals Profit Margin (Quarterly) : 16.50% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 16.50% |
| March 31, 2026 | 3.75% |
| December 31, 2025 | 13.34% |
| September 30, 2025 | 9.04% |
| June 30, 2025 | 17.79% |
| March 31, 2025 | 14.83% |
| December 31, 2024 | 20.35% |
| September 30, 2024 | 21.14% |
| June 30, 2024 | 20.81% |
| March 31, 2024 | 25.13% |
| December 31, 2023 | 20.31% |
| September 30, 2023 | 27.26% |
| June 30, 2023 | 17.93% |
| March 31, 2023 | 18.59% |
| December 31, 2022 | 25.12% |
| September 30, 2022 | 13.21% |
| June 30, 2022 | 14.05% |
| March 31, 2022 | 20.15% |
| December 31, 2021 | 16.35% |
| September 30, 2021 | 27.59% |
| June 30, 2021 | 8.48% |
| March 31, 2021 | 3.84% |
| December 31, 2020 | -6.04% |
| September 30, 2020 | 5.74% |
| June 30, 2020 | -1.67% |
| Date | Value |
|---|---|
| March 31, 2020 | 4.16% |
| December 31, 2019 | 0.91% |
| September 30, 2019 | 1.23% |
| June 30, 2019 | 59.36% |
| March 31, 2019 | -2.70% |
| December 31, 2018 | 1.92% |
| September 30, 2018 | 2.14% |
| June 30, 2018 | -4.02% |
| March 31, 2018 | -12.23% |
| December 31, 2017 | 1.30% |
| September 30, 2017 | 0.30% |
| June 30, 2017 | 3.03% |
| March 31, 2017 | 1.58% |
| December 31, 2016 | -4.32% |
| September 30, 2016 | 6.06% |
| June 30, 2016 | 10.13% |
| March 31, 2016 | 4.19% |
| December 31, 2015 | 9.79% |
| September 30, 2015 | -4.71% |
| June 30, 2015 | -12.34% |
| March 31, 2015 | -1.17% |
| December 31, 2014 | -4.51% |
| September 30, 2014 | -9.01% |
| June 30, 2014 | -2.41% |
| March 31, 2014 | -3.53% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Viatris, Inc. | -3.16% |
| Johnson & Johnson | 21.86% |
| Eli Lilly & Co. | 30.88% |
| Merck & Co., Inc. | -8.06% |
| Pfizer Inc. | -1.64% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 10.16% |
| Return on Assets | 4.70% |
| Return on Invested Capital | 5.45% |
| Gross Profit Margin (Quarterly) | 48.73% |
| Operating Margin (Quarterly) | 21.60% |
| Return on Net Operating Assets | 6.16% |